231 related articles for article (PubMed ID: 32370142)
21. Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma.
Sasahira T; Ueda N; Yamamoto K; Kurihara M; Matsushima S; Bhawal UK; Kirita T; Kuniyasu H
PLoS One; 2014; 9(3):e92534. PubMed ID: 24647631
[TBL] [Abstract][Full Text] [Related]
22. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells.
Pan MR; Chang TM; Chang HC; Su JL; Wang HW; Hung WC
J Cell Sci; 2009 Sep; 122(Pt 18):3358-64. PubMed ID: 19706680
[TBL] [Abstract][Full Text] [Related]
23. Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system.
Laerm A; Helmbold P; Goldberg M; Dammann R; Holzhausen HJ; Ballhausen WG
J Hepatol; 2007 Jan; 46(1):89-97. PubMed ID: 17069925
[TBL] [Abstract][Full Text] [Related]
24. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma.
Shen Y; Xia E; Bhandari A; Wang X; Guo G
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061172
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
Versmold B; Felsberg J; Mikeska T; Ehrentraut D; Köhler J; Hampl JA; Röhn G; Niederacher D; Betz B; Hellmich M; Pietsch T; Schmutzler RK; Waha A
Int J Cancer; 2007 Aug; 121(3):547-54. PubMed ID: 17415710
[TBL] [Abstract][Full Text] [Related]
26. Prox1 expression is negatively regulated by miR-181 in endothelial cells.
Kazenwadel J; Michael MZ; Harvey NL
Blood; 2010 Sep; 116(13):2395-401. PubMed ID: 20558617
[TBL] [Abstract][Full Text] [Related]
27. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.
Mishima K; Watabe T; Saito A; Yoshimatsu Y; Imaizumi N; Masui S; Hirashima M; Morisada T; Oike Y; Araie M; Niwa H; Kubo H; Suda T; Miyazono K
Mol Biol Cell; 2007 Apr; 18(4):1421-9. PubMed ID: 17287396
[TBL] [Abstract][Full Text] [Related]
28. Modulation of transcriptional corepressor activity of prospero-related homeobox protein (Prox1) by SUMO modification.
Shan SF; Wang LF; Zhai JW; Qin Y; Ouyang HF; Kong YY; Liu J; Wang Y; Xie YH
FEBS Lett; 2008 Nov; 582(27):3723-8. PubMed ID: 18948102
[TBL] [Abstract][Full Text] [Related]
29. PROX1 is a transcriptional regulator of MMP14.
Gramolelli S; Cheng J; Martinez-Corral I; Vähä-Koskela M; Elbasani E; Kaivanto E; Rantanen V; Tuohinto K; Hautaniemi S; Bower M; Haglund C; Alitalo K; Mäkinen T; Petrova TV; Lehti K; Ojala PM
Sci Rep; 2018 Jun; 8(1):9531. PubMed ID: 29934628
[TBL] [Abstract][Full Text] [Related]
30. High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.
Kasurinen A; Gramolelli S; Hagström J; Laitinen A; Kokkola A; Miki Y; Lehti K; Yashiro M; Ojala PM; Böckelman C; Haglund C
Cancer Med; 2019 Nov; 8(16):6995-7005. PubMed ID: 31560170
[TBL] [Abstract][Full Text] [Related]
31. Gene regulation by homeobox transcription factor Prox1 in murine hepatoblasts.
Papoutsi M; Dudas J; Becker J; Tripodi M; Opitz L; Ramadori G; Wilting J
Cell Tissue Res; 2007 Nov; 330(2):209-20. PubMed ID: 17828556
[TBL] [Abstract][Full Text] [Related]
32. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.
Hoffmann S; Maschuw K; Hassan I; Wunderlich A; Lingelbach S; Ramaswamy A; Hofbauer LC; Zielke A
Endocrine; 2006 Aug; 30(1):129-38. PubMed ID: 17185801
[TBL] [Abstract][Full Text] [Related]
33. Homeobox transcription factor Prox1 in sympathetic ganglia of vertebrate embryos: correlation with human stage 4s neuroblastoma.
Becker J; Wang B; Pavlakovic H; Buttler K; Wilting J
Pediatr Res; 2010 Aug; 68(2):112-7. PubMed ID: 20453716
[TBL] [Abstract][Full Text] [Related]
34. PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.
Hagiwara K; Ito H; Murate T; Miyata Y; Ohashi H; Nagai H
Genes Chromosomes Cancer; 2012 Nov; 51(11):1024-36. PubMed ID: 22833470
[TBL] [Abstract][Full Text] [Related]
35. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
[TBL] [Abstract][Full Text] [Related]
36. DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein.
Wang B; Huang J; Zhou J; Hui K; Xu S; Fan J; Li L; Wang X; Hsieh JT; He D; Wu K
Cell Signal; 2016 Nov; 28(11):1623-30. PubMed ID: 27476001
[TBL] [Abstract][Full Text] [Related]
37. Altered regulation of Prox1-gene-expression in liver tumors.
Dudas J; Mansuroglu T; Moriconi F; Haller F; Wilting J; Lorf T; Füzesi L; Ramadori G
BMC Cancer; 2008 Apr; 8():92. PubMed ID: 18400094
[TBL] [Abstract][Full Text] [Related]
38. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of podoplanin expression by Prox1 in lymphatic endothelial cells.
Pan Y; Wang WD; Yago T
Microvasc Res; 2014 Jul; 94():96-102. PubMed ID: 24944097
[TBL] [Abstract][Full Text] [Related]
40. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.
Shin JW; Min M; Larrieu-Lahargue F; Canron X; Kunstfeld R; Nguyen L; Henderson JE; Bikfalvi A; Detmar M; Hong YK
Mol Biol Cell; 2006 Feb; 17(2):576-84. PubMed ID: 16291864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
